Treating Acid Reflux Reduces Asthma Symptoms

JANUARY 01, 2003
Daily use of a proton pump inhibitor (PPI) to treat acid reflux reduces asthma exacerbations and improves general well-being in people with both severe asthma and symptoms of acid reflux. Researchers reported this finding at the 67th Annual Scientific Meeting of the American College of Gastroenterology, held October 21-23, 2002, in Seattle, Wash. The study involved 207 people with asthma who had symptoms of acid reflux. A significant reduction in severe asthma attacks was found among subjects with severe asthma (ie, those who took more than 1 long-term maintenance medication) who were randomized to a PPI. Improved quality of life was also found among this subgroup. The improvements associated with the use of a PPI were not found among subjects with less severe asthma, however.

SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.